Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 2
2005 1
2006 3
2007 13
2008 27
2009 31
2010 12
2011 7
2012 16
2013 18
2014 21
2015 28
2016 36
2017 30
2018 30
2019 29
2020 21
2021 25
2022 23
2023 21
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiology of Renal Cell Carcinoma: 2022 Update.
Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, Kassouf W, Mitchell T, Montironi R, O'Brien T, Panebianco V, Scelo G, Shuch B, van Poppel H, Blosser CD, Psutka SP. Bukavina L, et al. Among authors: bensalah k. Eur Urol. 2022 Nov;82(5):529-542. doi: 10.1016/j.eururo.2022.08.019. Epub 2022 Sep 10. Eur Urol. 2022. PMID: 36100483 Review.
Epidemiology of Renal Cell Carcinoma.
Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, Gore JL, Sun M, Wood C, Russo P. Capitanio U, et al. Among authors: bensalah k. Eur Urol. 2019 Jan;75(1):74-84. doi: 10.1016/j.eururo.2018.08.036. Epub 2018 Sep 19. Eur Urol. 2019. PMID: 30243799 Free PMC article. Review.
Immunotherapy in Renal Cell Carcinoma: The Future Is Now.
Deleuze A, Saout J, Dugay F, Peyronnet B, Mathieu R, Verhoest G, Bensalah K, Crouzet L, Laguerre B, Belaud-Rotureau MA, Rioux-Leclercq N, Kammerer-Jacquet SF. Deleuze A, et al. Among authors: bensalah k. Int J Mol Sci. 2020 Apr 5;21(7):2532. doi: 10.3390/ijms21072532. Int J Mol Sci. 2020. PMID: 32260578 Free PMC article. Review.
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
Méjean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Beisland C, Aitchison M, Oudard S, Patard JJ, Theodore C, Chevreau C, Laguerre B, Hubert J, Gross-Goupil M, Bernhard JC, Albiges L, Timsit MO, Lebret T, Escudier B. Méjean A, et al. Among authors: bensalah k. N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3. N Engl J Med. 2018. PMID: 29860937 Free article. Clinical Trial.
Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients.
Saout JR, Lecuyer G, Léonard S, Evrard B, Kammerer-Jacquet SF, Noël L, Khene ZE, Mathieu R, Brunot A, Rolland AD, Bensalah K, Rioux-Leclercq N, Lardenois A, Chalmel F. Saout JR, et al. Among authors: bensalah k. Eur Urol. 2023 May;83(5):441-451. doi: 10.1016/j.eururo.2023.02.008. Epub 2023 Feb 15. Eur Urol. 2023. PMID: 36801089 Free article.
Reply by Authors.
Krabbe LM, Heitzplatz B, Preuss S, Hutchinson RC, Woldu SL, Singla N, Boegemann M, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Rapoport LM, Glybochko PV, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Xylinas E, Margulis V. Krabbe LM, et al. Among authors: bensalah k. J Urol. 2018 May;199(5):1353-1354. doi: 10.1016/j.juro.2017.11.138. Epub 2018 Feb 9. J Urol. 2018. PMID: 29428629 Free PMC article. No abstract available.
Stones in special situations.
Duvdevani M, Sfoungaristos S, Bensalah K, Peyronnet B, Krambeck A, Khadji S, Muslumanuglu A, Leavitt D, Divers J, Okeke Z, Smith A, Fox J, Ost M, Gross AJ, Razvi H. Duvdevani M, et al. Among authors: bensalah k. World J Urol. 2017 Sep;35(9):1381-1393. doi: 10.1007/s00345-017-2011-y. Epub 2017 Mar 7. World J Urol. 2017. PMID: 28271156 Review.
Radiogenomics in prostate cancer evaluation.
Thenault R, Gasmi A, Khene ZE, Bensalah K, Mathieu R. Thenault R, et al. Among authors: bensalah k. Curr Opin Urol. 2021 Jul 1;31(4):424-429. doi: 10.1097/MOU.0000000000000902. Curr Opin Urol. 2021. PMID: 34009176 Review.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Vano YA, Elaidi R, Bennamoun M, Chevreau C, Borchiellini D, Pannier D, Maillet D, Gross-Goupil M, Tournigand C, Laguerre B, Barthélémy P, Coquan E, Gravis G, Houede N, Cancel M, Huillard O, Beuzeboc P, Fournier L, Méjean A, Cathelineau X, Doumerc N, Paparel P, Bernhard JC, de la Taille A, Bensalah K, Tricard T, Waeckel T, Pignot G, Braychenko E, Caruso S, Sun CM, Verkarre V, Lacroix G, Moreira M, Meylan M, Bougouïn A, Phan L, Thibault-Carpentier C, Zucman-Rossi J, Fridman WH, Sautès-Fridman C, Oudard S. Vano YA, et al. Among authors: bensalah k. Lancet Oncol. 2022 May;23(5):612-624. doi: 10.1016/S1470-2045(22)00128-0. Epub 2022 Apr 4. Lancet Oncol. 2022. PMID: 35390339 Clinical Trial.
Genomics in upper tract urothelial carcinoma.
Kammerer-Jacquet SF, Mathieu R, Peyronnet B, Rioux-Leclercq N, Bensalah K. Kammerer-Jacquet SF, et al. Among authors: bensalah k. Curr Opin Urol. 2017 Jan;27(1):35-40. doi: 10.1097/MOU.0000000000000341. Curr Opin Urol. 2017. PMID: 27584028 Review.
303 results